Interview/Debate at 4xCiência
At the 4xCiência Show, hosted by Sandra Inês Cruz, discussing Bioinformatics with Prof. Arlindo Oliveira (IST) and Prof. José Guedes de Oliveira (INESC TEC)
Similar Posts
The Localisation Trap: GCC Needs a Regional Diagnostics Strategy, Not Six National Ones
Over the past several weeks I have been reading the many analyses coming out of Gulf policy circles. Carnegie’s three scenarios for GCC states after the Iran war. The Al Jazeera opinions arguing that joint defence and integrated development are now the only credible regional agenda. The Middle East Council’s assessment of Qatar’s strategic position…
In defense of Molecular Diagnostics innovation and manufacture as a relevant sector for Portugal
Opinion published (in Portuguese) on the national newspaper Diário de Notícias where I defend the need that the discovery and manufacture of innovative Molecular Diagnostics (In Vitro Diagnostics Medical Devices) should be a priority for academia, Government and Investors, considering the current landscape of R&D and Investment capability. I believe that focusing on this sector…
On WebSummit 2025
Published on linkedin A few days after Web Summit Lisbon 2025, one impression remains very clear to me: how differently national hashtag#innovationecosystems choose to present themselves. As someone working at the intersection of precision diagnostics and ecosystem development, I pay attention not only to the technologies on display but to the systems behind them. One of the…
Speaker: Investment & Innovation potential in Life Sci.
On Nov 16th, 2017 I gave a talk at the I annual meeting of the Associação de Consultores de Investimento e Inovação de Portugal about the Potential for Investment and Innovation of the Life Sciences. I discussed changing trends in Biomedical sciences and the health sector, and the opportunities arising. I also discussed the Portuguese…
Movimento Ciência Portugal – 2011
Following the election of new government, and at the onset of a major financial crisis that lasts to these days, some of us (scientists) were very worried by a shift in funding of science from basic to applied. It was (and is) our conviction that without a solid foundation in basic science no disruptive innovation…
Precision Diagnostics in Saudi Arabia? The beauty of Scale
by Jose Leal, 5th December 2025 Where should we build the next stage of our work? This question has been driving my thinking about the Gulf for the past year. As Ophiomics moves from clinical validation into manufacturing and regional deployment, I need to understand not just market sizes or tender processes, but what each country’s…